A report by MarketsandMarkets analyzes and studies the major technology and market drivers, restraints and opportunities in North America, Europe, Asia and Rest of the World.

Vasomedical Inc. announced that the FDA issued its final order Dec. 30, 2013, reclassifying external counterpulsation (ECP) devices for treatment of chronic stable angina for patients that are refractory to antianginal medical therapy and without options for revascularization from class III to class II (special controls).

The winners of the Right Dose Image Contest were announced at theĀ Radiological Society of North America Annual MeetingĀ (RSNA 2013) in Chicago.Ā 

Stentys, developer of the world's first self-apposingĀ stentĀ to treat acute myocardial infarction (AMI), announced new data in indications outside of myocardial infarction.

Barco, a visualization technology company, and Brainlab AG, Germany-based medical software technology manufacturer and marketer, announced their collaboration to provide medical content distribution and sharing.


The annual Radiological Society of North America (RSNA) scientific assembly and annual meeting is where imaging systems vendors showcase their latest technology. While aimed at the radiology market, imaging systems specific to cardiovascular specialties are often highlighted at RSNA first.


Subscribe Now